When combined with the establishment of a resident memory CD8+ T cell population in the lungs, our data suggest that AdCOVID has the potential to confer long lasting protective immunity, particularly within the bronchoalveolar space and lungs, which represent major sites of infection and clinical disease. Here, CD8A is linked to infection.